After 23 years in private practice and observing that the "mental health" field has become dominated by psychiatric labels and drugs and is doing more harm than help, I closed my office to devote myself full-time to efforts to reform the field and inform the public about the damage and disability caused by psychotropic drugs, especially when given to children whose brains are still developing.

Currently, I teach seminars, provide expert testimony on legislation, and do public speaking to a wide range of audiences. I have been interviewed on radio stations across the country and on TV about the state of the "mental health" field. Additionally, I have been featured in two documentaries. 
Dr. Linda Lagemann

Linda Lagemann, Ph.D.

Licensed Clinical Psychologist PSY15498
phone: 415-640-7343
email: 2DrLagemann@gmail.com
www.dsmcontroversy.com

DR. LAGEMANN QUOTE FOR THE DAY: "Abilify is the new Prozac"

Research firm IMS compiled a 12-month history (October 2013 to September 2014) of the top 100 drugs by total prescriptions and total sales in the United States.

The cholesterol-lowering drug rosuvastatin (Crestor, AstraZeneca) edged out the hypothyroid drug levothyroxine (Synthroid, AbbVie) as the most prescribed drug in the United States, and the antipsychotic medication aripiprazole (Abilify, Otsuka Pharmaceutical) remains the best-selling drug, according to recent data.

So, an anti-psychotic is the top-selling drug in the United States. The original market for anti-psychotics is very small. With brilliant marketing and Direct-to-Consumer-Advertising access to virtually every home in America, millions of people are taking anti-psychotics for depression and giving them to their children for ADHD. The damage being done is incalculable.

Website Builder